Humana is seeing shares up at new year highs in pre-market trading this morning. The health insurer posted $1.53 EPS versus the $1.48 estimate on revenues of $6.32 Billion versus the $6.22 Billion estimate. Humana now sees 2007 EPS $4.75 to $4.80 versus a consensus estimate of $4.52 per share. It also put 2008 earnings above plan with a new range of $5.30 to $5.50 EPS, while consensus estimates are $5.20.
Its expense ratios greatly improved. The consolidated medical expense ratio mast quarter (MER) of 81.3% was 280 basis points lower than the 3Q 2006 MER of 84.1%, the combined result of a 360 basis point decline in the Government Segment MER. The consolidated MER for Year to Date 2007 of 83.8% was 50 basis points lower than the Year to date 2006 consolidated MER of 84.3%, substantially due to the same factors driving the year-over-year improvement in 3Q07.
Shares are trading up at $80.00 pre-market, and the 52-week trading range is $51.00 to $77.83. Memories of major woes just a few years ago are getting harder and harder to think about.
Jon C. Ogg
October 29, 2007
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
